Blood-Brain Barrier Acts as Intelligent Filter, New Alzheimer's Approach Possible
Researchers have discovered that the blood-brain barrier, a network of blood vessel cells separating the brain from the bloodstream, functions as a sophisticated filter that actively transports beneficial proteins into the brain. This finding could lead to novel treatments for Alzheimer's and other diseases, ET Healthworld reported.

Andrew Yang of the Gladstone Institutes in San Francisco, the study leader, stated that for a century, the blood-brain barrier was viewed as a simple physical protector against toxins. He added that researchers are now finding it to be an intelligent interface that selects specific blood proteins, often from distant parts of the body, and delivers them to the correct brain cell types.
Working with mice, the research team used protein-labeling chemistry to tag 861 mouse blood proteins, which were then re-injected into the bloodstream. Subsequent analyses of brain tissue revealed that 92 of these proteins successfully crossed the blood-brain barrier. Once inside the brain, different proteins were directed to specific types of brain cells, as reported in Cell. Many of these proteins originated from distant body parts; for instance, the liver protein apolipoprotein A1 (APOA1) travels to the brain to support healthy neuronal connections. This particular discovery could open avenues for new Alzheimer's disease treatments.
Yang suggested that Alzheimer's disease might not originate entirely within the brain, but rather when the brain's supply line from the body is compromised. He posited that fighting the disease from outside the brain, by restoring what the brain has lost, could be a viable approach. In studies with mice exhibiting a form of Alzheimer's, researchers observed that if the blood-brain barrier ceased importing APOA1 into the brain, the reduced supply led to an erosion of neuronal connections, behavioral changes, and other early disease indicators. Conversely, mice genetically engineered to produce extra APOA1 in the liver showed more APOA1 crossing the blood-brain barrier into the brain, resulting in fewer signs of Alzheimer's disease.
Yang noted that a map now exists of the proteins the brain needs from the body and the transport system that delivers them. He expressed excitement about translating this blueprint into new Alzheimer's therapies that operate from the outside-in, as well as into next-generation blood-brain barrier shuttles for delivering potent medicines to the brain.
In other health news, a first-in-human trial demonstrated that a therapy derived from human placentas healed chronic diabetic foot wounds that had resisted standard treatments. Ten study participants with substantial wounds, according to a report in Stem Cells Translational Medicine, received a single treatment of investigational cells from healthy placental tissue. Two participants achieved wound healing within two months, and all ten experienced complete wound closure within six months. Dr. Michael Carstens of the Wake Forest Institute for Regenerative Medicine, a study coauthor, confirmed the cells were well tolerated, with no treatment-related serious adverse events during 12 months of follow-up. Nine patients also showed improved sensation in their treated feet, suggesting potential for treating peripheral neuropathy.
Separately, California researchers reported at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix that children whose mothers inhaled wildfire smoke and other air pollution during the second and third trimesters of pregnancy were more likely to develop asthma. Dr. Anh Nguyen of UC Davis Medical Center, the study leader, highlighted that a baby's lung development begins before birth and certain pregnancy stages may be particularly vulnerable. The study, involving 1,097 children born full-term after the 2017-2020 Northern California wildfires, linked early childhood asthma to higher fine-particle air pollution exposure in the second trimester and wildfire pollution in the third. While not proving causation, the findings can help doctors advise pregnant women on mitigating smoke exposure.
Editor's note: The report effectively synthesizes the three distinct medical research topics covered in the source material.
AI-generated and fact-checked against the original report; claims the gate cannot verify are held back.